INTRODUCTION
Overweight is defined as a body mass index (BMI) from 25 to 29.9 kg/m 2 and obesity, as a BMI higher than 30 mg/m 2 (1,2). Worldwide, obesity has doubled since 1980, and in 2014 more than 1.9 billions of adults over 18 years were overweight, more than 600 million of whom are obese (1, 2) . In 2012, the national health survey reported that 73% of women and 69.4% of men in Mexico have some degree of obesity or overweight (3) . Currently, high BMI is considered as a major health problem that is associated directly with high mortality and serves as a trigger to develop cardiovascular, metabolic, musculoskeletal and oncologic diseases (4, 5) . According to data from the Institute for Health Metrics and Evaluation (IMHE) for 2010, 70% of the adult population over 20 years had some degree of obesity or overweight (6) . Obesity and overweight are considered as chronic inflammatory processes with consequent changes in immune response of acute events, such as sepsis (7) (8) (9) (10) (11) (12) . It has been reported that obesity is associated with 20% in women and 14% in men of all causes of death of oncologic patients (13) , and obesity is considered to be a factor related to the development of multiple neoplasia (10) . However, in the context of critically ill oncologic patients with high BMI, the impact on mortality is unknown. Different reports have described that in patients with sepsis and septic shock, obesity is a protective factor against death (14) (15) (16) (17) (18) .
The purpose of this study was to describe the incidence of obesity and overweight in critically ill cancer patients, and to evaluate the clinical characteristics and Intensive Care Unit (ICU) outcomes of critically ill cancer patients with obesity and overweight.
METHODS
This prospective, observational cohort study was performed at the Instituto Nacional de Cancerología (INCan) located in Mexico City. We included all consecutive critically ill cancer patients admitted to the ICU during the period between January 2013 and April 2015. Critically ill cancer patients over 18 years of age with more than 12 hours of stay in the ICU were included. We registered the demographic, clinical and laboratory data of the patients during their stay in the ICU, including age, gender, weight at admission to ICU, size, oncologic disease, comorbidities, organic support requirement, days of ICU stay, days of invasive mechanical ventilation, sepsis and mortality in the ICU. Sepsis was defined according to the Third International Consensus Definitions for Sepsis and Septic Shock (19) . We calculated the Acute Physiology and Chronic Health Evaluation (APACHE) II score (20) during the first 24 hours of ICU stay; Sequential Organ Failure Assessment (SOFA) (21, 22) and the Mexican sequential organ failure assessment (MEXSOFA) scores (23) for the evaluation of organic failures were also calculated. The APACHE II, SOFA and MEXSOFA scores were calculated with the worst clinical and laboratory values during the first 24 hours of ICU stay. We calculated the BMI with the weight and size recorded at the time of the acute event for which the patient admitted to the ICU, and data were To compare the continuous variables, we used Student's t test or Mann-Whitney U test according to the sample distribution. For the analysis of the categorical variables, the χ 2 test was used. Survival curves were constructed using the Kaplan-Meier method, and compared with the log-rank method. Univariate and multivariate logistic regressions were used to identify factors associated with hospital mortality. Variables with a p < 0.2 in the univariate analysis were entered into the model using a forward stepwise procedure. The results were summarized as odds ratios (ORs) and respective 95% confidence intervals (CI). The area under the receiver operating characteristic curve was used to evaluate the ability of the model to discriminate between patients who lived and those who died (discrimination). Goodness-of-fit (Hosmer-Lemeshow) was calculated to assess the relevance of the logistic regression model. In all cases, a p value of < 0.005 was considered as statistically significant. SPSS 22.0 was used.
RESULTS
During the study period, 483 critically ill cancer patients were admitted to the ICU; 59.2% (258 patients) had high BMI. The mean age was 48.4 ± 16.6 years, and 53.2% of the patients were women. One hundred and twenty-one ICU admissions (25.1%) were due to septic shock. The second most common cause for ICU admission was acute respiratory failure, with 82 (17.2%) ICU admissions, and all of those patients required mechanical ventilation. Table I shows the clinical characteristics of the patients on admission to the ICU. (Table III) .
Multivariate analysis identified ≥ 2 organ failures as independent prognostic factor of ICU death (Table III) .
DISCUSSION
The main findings of the present study were as follow: 1. The incidence of high BMI was 59.2%. 2. The group of patients with BMI ≥ 25 kg/m 2 were older, and required long-term mechanical ventilation. 3. The ICU mortality of patients with BMI < 25 kg/m 2 and ≥ 25 kg/m 2 was similar. The ICU mortality in critically ill patients with a BMI ≥25 kg/m 2 depends primarily on the number of organ failures, especially when two or more organs are affected. The incidence of high BMI in patients enrolled in the present study was higher than those described by other authors, who have report- ed an incidence ranging from 5-25% (5, 7, 8, 14, (25) (26) (27) , similar to the data shown in the national health survey of 2012. In the general population, an increase in the incidence of oncologic diseases was observed, which may be associated with the advent of new diagnostic techniques and treatment protocols for oncologic patients, thus allowing an improvement of the survival rate. The above is a possible explanation for the fact that oncologic patients have anthropometric characteristics similar to the general population.
Critically ill oncologic patients have the same risk to develop cardiovascular and metabolic diseases. The group of patients with overweight and obesity are at a major risk of developing chronic diseases, such as systemic arterial hypertension and diabetes mellitus; however, in our study, less than 20% of the patients had a history of those clinical entities (15, 28) .
The organ failure that occurred more frequently in patients with a BMI ≥ 25 kg/m 2 was respiratory failure; however, the incidence was similar in the group of BMI < 25 kg/m 2 although overweight and obese patients have decreased lung compliance, functional residual capacity and total vital capacity (29) (30) (31) (32) (33) . In addition to the pathophysiological differences in the respiratory mechanics of both groups, the use of long-term mechanical ventilation was only observed in the group of BMI ≥ 25 kg/m 2 compared to those with BMI < 25 kg/m 2 . Patients with a high BMI have an increased risk to develop acute respiratory distress syndrome, and therefore need a longer ventilatory support without influencing in their prognosis (33, 34) .
Several authors have described that patients without cancer with certain degrees of obesity have better survival to clinical conditions that endanger life during the ICU stay, which has been defined as paradoxical obesity (15, 26, 27) . In contrast, the results of the present study, which included only critically ill oncologic patients, failed to establish an association between high BMI and better prognosis in ICU; therefore, the ICU mortality of patients with BMI < 25 kg/m 2 and ≥ 25 kg/m 2 was similar. In the study by El-Solh et al. (35) , morbidly obese patients in a medical ICU found the presence of organ failures to be the strongest independent predictor of mortality in these patients. Our study found that the ICU mortality in critically ill patients with a BMI ≥ 25 kg/ m 2 depends primarily on the number of organ failures, especially when two or more organs are affected.
It is known that paradoxical obesity represents a good prognostic factor in the evolution of certain entities, such as in acute coronary syndromes, chronic heart failure, chronic renal disease and pneumonia (36) (37) (38) (39) . Gruber et al. described the concept of paradoxical obesity in 2002 by suggesting obesity as a good prognostic factor in patients undergoing percutaneous transluminal coronary angioplasty in short and long term (36) . Recently, González et al. (37) reported that ambulatory patients with cancer and sarcopenia (low rate of fat-free mass) have a higher risk of death. The few reports that include oncologic patients suggest that obesity is a factor to consider in the response to oncologic treatment, and in the progression and resolution of oncologic disease over the medium or long term (40) (41) (42) . In our institution, there are no statistics regarding the incidence of overweight and obesity in oncologic patients. According to the results of the present study, approximately six of every ten patients admitted for a serious condition to the ICU are overweight or show some degree of obesity, which could be a projection of high BMI in the oncologic population treated at our institution.
The main limitations of this work are as follows: 1. It represents the experience of a single health institution.
2. The relatively small sample size.
CONCLUSION
Critically ill cancer patients have a high incidence of high BMI; approximately six of every ten patients admitted to the ICU with a serious condition are overweight or show several degrees of obesity. The ICU mortality of the patients with a body mass index < 25 kg/m 2 and ≥ 25 kg/m 2 was similar. The independent prognostic factor of ICU death in critically ill patients with a BMI ≥ 25 kg/m 2 was the number of organ dysfunctions, especially when two or more organs are affected.
